Here, we demonstrated for the first time that (−)-oleocanthal inhibited HCC growth and metastasis both in vitro and in vivo, at least in part by inhibiting the activity of STAT3 and its gene products. The gene discussed is STAT3; the disease is hepatocellular carcinoma.